Volume 38; Issue supp-S5

Main
European Journal of Cancer
Volume 38; Issue supp-S5

European Journal of Cancer

Volume 38; Issue supp-S5

1

Introduction

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 29 KB

english, 2002

2

Significance of tyrosine kinases in cancer: overview

Leif C. Andersson

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 31 KB

english, 2002

3

Regulation and targets of receptor tyrosine kinases

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 889 KB

english, 2002

4

Tyrosine kinases as targets for cancer therapy

Alexander Levitzki

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 262 KB

english, 2002

5

Imatinib: a selective tyrosine kinase inhibitor

P.W. Manley, S.W. Cowan-Jacob, E. Buchdunger, D. Fabbro, G. Fendrich, P. Furet, T. Meyer, J. Zimmermann

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 618 KB

english, 2002

6

Pharmacology of imatinib (STI571)

Elisabeth Buchdunger, Terence O'Reilley, Jeanette Wood

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 867 KB

english, 2002

7

Clinical presentation of gastrointestinal stromal tumors and treatment of operable disease

Peter J. Roberts, Burton Eisenberg

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 42 KB

english, 2002

8

Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review

Markku Miettinen, Mourad Majidi, Jerzy Lasota

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 672 KB

english, 2002

9

Identification and treatment of chemoresistant inoperable or metastatic GIST: experience with the selective tyrosine kinase inhibitor imatinib mesylate (STI571)

George D. Demetri

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 454 KB

english, 2002

10

Use of positron emission tomography in oncology and its potential role to assess response to imatinib mesylate therapy in gastrointestinal stromal tumors (GISTs)

Annick D. Van den Abbeele, Ramsey D. Badawi

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 869 KB

english, 2002

11

Overview of issues related to imatinib therapy of advanced gastrointestinal stromal tumors: a discussion among the experts

Sandra Silbermann, Heikki Joensuu

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 64 KB

english, 2002

12

Imatinib and chronic myeloid leukemia: validating the promise of molecularly targeted therapy

Brian J. Druker

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 370 KB

english, 2002

13

Imatinib: the first 3 years

Renaud Capdeville, Sandra Silberman, Sasa Dimitrijevic

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 97 KB

english, 2002

14

Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group

Allan T. van Oosterom, Ian R. Judson, Jaap Verweij, Sigrid Stroobants, Herlinde Dumez, Eugenio Donato di Paola, Raf Sciot, Martine Van Glabbeke, Sasa Dimitrijevic, Ole S. Nielsen

Journal:

European Journal of Cancer

Year:

2002

Language:

english

File:

PDF, 292 KB

english, 2002

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Tor version

Z-Library

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски